At the 2018 Internationale Funkausstellung (IFA, August 31 - September 5, Berlin, Germany), Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced a range of intelligent, adaptive, personalized consumer health solutions that empower people to improve their health and well-being every day. 
Changing the experience of health: that's the focus of the six startups which the Bayer G4A team has included in the Accelerator program this year. The young companies from Canada, Germany, Israel, Spain, the United Kingdom and the United States came out ahead of more than 1,800 competitors from 100 countries. They now have 100 days in which to intensively drive the further development of their products and solutions with expertise and investment from Bayer. 
A substantial number of acute hospitals in England are not taking important steps to prevent staff sharing sensitive information via WhatsApp, Facebook Messenger and other consumer applications, a series of Freedom of Information Act requests has revealed. Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced the EPIQ CVx cardiovascular ultrasound system. Built on the powerful EPIQ ultrasound platform, EPIQ CVx is specifically designed to increase diagnostic confidence and simplify workflow for clinicians, giving them more time to interact with their patients and reducing the need for repeat scans. 
Cerner has announced a new collaboration with North London Partners (NLP) - a partnership of health and care organisations across five London boroughs - to connect care information, share records, and apply advanced intelligence across North London to support their population health management initiatives, covering almost 1.5 million citizens. 
The U.S. Food and Drug Administration permitted marketing of the first mobile medical application (app) that can be used as a method of contraception to prevent pregnancy. The app, called Natural Cycles, contains an algorithm that calculates the days of the month a woman is likely to be fertile based on daily body temperature readings and menstrual cycle information, a method of contraception called fertility awareness.